MARKET

CLLS

CLLS

Cellectis
NASDAQ
1.515
+0.005
+0.33%
Opening 10:28 01/22 EST
OPEN
1.520
PREV CLOSE
1.510
HIGH
1.522
LOW
1.500
VOLUME
13.68K
TURNOVER
--
52 WEEK HIGH
3.380
52 WEEK LOW
1.410
MARKET CAP
151.65M
P/E (TTM)
-8.6276
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CLLS last week (0113-0117)?
Weekly Report · 2d ago
Cellectis S.A announces potential resale of up to 44M shares
Seeking Alpha · 6d ago
Cellectis files to sell 44M ordinary shares for holders
TipRanks · 6d ago
Weekly Report: what happened at CLLS last week (0106-0110)?
Weekly Report · 01/13 09:39
Do Options Traders Know Something About Cellectis (CLLS) Stock We Don't?
Barchart · 01/07 11:38
Biotech Alert: Searches spiking for these stocks today
TipRanks · 01/06 16:10
Weekly Report: what happened at CLLS last week (1230-0103)?
Weekly Report · 01/06 09:41
This Penny Stock Has 270% Upside Potential in 2025. Is It a Buy Now?
Barchart · 01/03 09:17
More
About CLLS
Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development, and commercialization of rational genome engineering technologies. The Company develops immunotherapies that aim to force the immune system to target and eradicate cancer cells. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement. Cellectis SA markets its technologies mainly for use in the research field, in pharmaceutical drug discovery programs, in the agronomics, bioproduction, and biotherapeutics fields. Cellectis SA operates several subsidiaries. The Company operates in France and the United States, among others.

Webull offers Cellectis SA (ADR) stock information, including NASDAQ: CLLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLLS stock methods without spending real money on the virtual paper trading platform.